Specialty	Surgical Oncology
Clinical Interests	Liver Transplant
	Surgery, Biliary
	Surgery, Hepatobiliary
	Surgery, Liver
	Surgery, Pancreatic
	Surgery, Transplant
Languages	English
Gender	Male
E-mail	sasan.roayaie@mssm.edu
Education and Training	MD, New Jersey Medical School
	Residency, Surgery, Mount Sinai Hospital
	Residency, Surgery, Mount Sinai Hospital
	Fellowship, Transplant Surgery, Mount Sinai Hospital
	Fellowship, Liver Transplant, Mount Sinai Hospital
Awards	2001 NIH K-30 Clinical Investigator Training AwardNew award
	2000 David A Dreiling Award for Best Academic Achievement among Chief Residents
	1994 Drs. Milton & Rose Prystowsky Award for Overall Excellence in Patient Care
	1993 Alpha Omega Alpha National Honor Society

Dr. Roayaie's areas of interest are adult liver transplantation including cadaver and living donor; and hepatobiliary surgery involving resection of tumors of the liver, bile ducts, and pancreas.

Dr. Roayaie earned his M.D. from the New Jersey Medical School. He was a member of the house staff at The Mount Sinai Hospital Department of Surgery before completing his Multiorgan Transplant fellowship here at RMTI. Among his many honors are the NIH K-30 Clinical Investigator Training Award in 2001; the Alpha Omega Alpha National Honor Society, member since 1993; and the Phi Beta Kappa National Honor Society, member since 1989. He also participated as a volunteer surgeon in Doctors Without Borders on an African Medical Mission to Transkei, South Africa. Dr. Roayaie is certified by the American Board of Surgery.

Education and Training	MD, New Jersey Medical School
	Residency, Surgery, Mount Sinai Hospital
	Residency, Surgery, Mount Sinai Hospital
	Fellowship, Transplant Surgery, Mount Sinai Hospital
	Fellowship, Liver Transplant, Mount Sinai Hospital

Specialty	Surgical Oncology
Clinical Interests	Liver Transplant
	Surgery, Biliary
	Surgery, Hepatobiliary
	Surgery, Liver
	Surgery, Pancreatic
	Surgery, Transplant
Languages	English

Dr. Roayaie's research activities are focused on the results of transplantation and liver resection for hepatocellular carcinoma; the prevention of recurrence of hepatocellular carcinoma after resection and transplant; and the results of transplant and re-transplant for hepatitis C.

Research

• Hepatobiliary surgery
• Benign and Malignant Tumors
• Hepatocellular Carcinoma

 

Roayaie S, Guarrera M, Ye M, Thung S, Emre S, Fishbein T, Guy S, Sheiner P, Miller C, Schwartz M. Aggressive surgical treatment of intrahepatic cholangiocarcinoma: predictors of outcome. J Am Coll Surg 1998; 187: 365-372.

Roayaie S, Wang L, Basile J, Boros P, Miller C. The influence of acute hepatic failure in the host on survival and function of cold preserved liver allografts. Surgical Forum 1998 XLIX;: 388-390.

Roayaie S, Sheiner P, Emre S, Guy S, Schwartz M, Boros P, Miller C. Cytokine profiles in early rejection following OKT3 treatment in liver transplant patients. Mediators of Inflammation 2000; 9: 125-130.

Roayaie S, Jossart G, Gitlitz D, Lamparello P, Hollier L, Gagner M. Laparoscopic release of celiac artery compression syndrome facilitated by laparoscopic ultrasonography to confirm restoration of flow. J Vasc Surg 2000; 32: 814-817.

Roayaie S, Emre S, Fishbein T, Sheiner P, Miller C, Schwartz M. Comparison of surgical outcomes for hepatocellular carcinoma in patients with and hepatitis B vs. hepatitis C. Ann Surg Onc 2000; 7: 764-770.

Roayaie S, Frischer S, Emre S, Fishbein T, Sheiner P, Sung M, Miller C, Schwartz M. Long term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5cm. Ann Surg 2002; 235: 533-539.

Munoz L, Roayaie S, Maman D, Fishbein T, Sheiner P, Emre S, Miller C, Schwartz M. Hilar cholangiocarcinoma involving the portal vein bifurcation: Long term results after resection . J Hepatobiliary Pancreat Surg 2002; 9(2): 237-241.

Gondolesi G, Roayaie S, Munoz L, Kim-Schluger L, Schiano T, Fishbein T, Emre S, Miller C, Schwartz ME. Adult Living Donor Liver Transplantation for Patients with Hepatcocellular Carcinoma. Annals of Surgery 2004 Feb; 239(2): 142-149.